• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葡糖脑苷脂酶缺乏对戈谢病和帕金森病患者同基因多巴胺能神经元中糖蛋白非转移性黑色素瘤蛋白B的双向调节

Bidirectional regulation of glycoprotein nonmetastatic melanoma protein B by β-glucocerebrosidase deficiency in isogenic dopaminergic neurons from a patient with Gaucher disease and parkinsonism.

作者信息

Chen Chase, Ma Charis, Sam Richard, Lichtenberg Jens, Chen Tiffany, Hao Ying, Li Ziyi, Kowal Isabelle, Andersh Kate, Qi Yue Andy, Perez Gani, Hertz Ellen, Li Yan, Williams Darian, Henderson Mark J, Park Morgan, Jiang Xuntian, Jerez Pilar Alvarez, Blauwendraat Cornelis, Sidransky Ellen, Chen Yu

机构信息

Molecular Neurogenetics Section, Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland, USA.

Aligning Science Across Parkinson's (ASAP) Collaborative Research Network, Chevy Chase, MD, 20815.

出版信息

bioRxiv. 2025 Jun 25:2025.06.23.661126. doi: 10.1101/2025.06.23.661126.

DOI:10.1101/2025.06.23.661126
PMID:40667145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12262256/
Abstract

Variants in are common genetic risk factors for several synucleinopathies. The increased risk has been attributed to the toxic effects of misfolded glucocerebrosidase (GCase) (gain-of-function), and the accumulation of lipid substrates due to reduced enzyme activity (loss-of-function). To delineate pathogenicity, an iPSC line was generated from a patient with both type 1 Gaucher disease (: N370S/N370S; p.N409S/p.N409S) and Parkinson disease (PD). From this line, we created a reverted wild-type (WT) line and a knockout (KO) line to eliminate misfolded GCase and intensify lipid accumulation. N370S/N370S and KO dopaminergic neurons (DANs) exhibited decreasing GCase levels and progressive accumulation of lipid substrates compared to WT DANs. Notably, the expression of , whose levels correlate with PD risk, was upregulated by the mild lipid accumulation in N370S/N370S DANs but disrupted in KO DANs. These findings refine the loss-of-function mechanism by associating PD risk levels of GPNMB with lipid levels specific to risk variants.

摘要

中的变体是几种突触核蛋白病常见的遗传风险因素。风险增加归因于错误折叠的葡萄糖脑苷脂酶(GCase)的毒性作用(功能获得),以及由于酶活性降低导致的脂质底物积累(功能丧失)。为了阐明其致病性,从一名同时患有1型戈谢病(:N370S/N370S;p.N409S/p.N409S)和帕金森病(PD)的患者中生成了一个诱导多能干细胞系。从该细胞系中,我们创建了一个回复野生型(WT)细胞系和一个基因敲除(KO)细胞系,以消除错误折叠的GCase并加剧脂质积累。与WT多巴胺能神经元(DANs)相比,N370S/N370S和KO多巴胺能神经元(DANs)的GCase水平降低,脂质底物逐渐积累。值得注意的是,其水平与PD风险相关的基因的表达在N370S/N370S DANs中因轻度脂质积累而上调,但在KO DANs中受到破坏。这些发现通过将GPNMB的PD风险水平与特定风险变体的脂质水平相关联,完善了功能丧失机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/4c7604299a4d/nihpp-2025.06.23.661126v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/2070b8546fa5/nihpp-2025.06.23.661126v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/6f523b8e854e/nihpp-2025.06.23.661126v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/33be5fc9323b/nihpp-2025.06.23.661126v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/f36701bc5fd5/nihpp-2025.06.23.661126v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/a5cd30fc6561/nihpp-2025.06.23.661126v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/fb53a2707cfd/nihpp-2025.06.23.661126v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/4c7604299a4d/nihpp-2025.06.23.661126v1-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/2070b8546fa5/nihpp-2025.06.23.661126v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/6f523b8e854e/nihpp-2025.06.23.661126v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/33be5fc9323b/nihpp-2025.06.23.661126v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/f36701bc5fd5/nihpp-2025.06.23.661126v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/a5cd30fc6561/nihpp-2025.06.23.661126v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/fb53a2707cfd/nihpp-2025.06.23.661126v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb05/12262256/4c7604299a4d/nihpp-2025.06.23.661126v1-f0007.jpg

相似文献

1
Bidirectional regulation of glycoprotein nonmetastatic melanoma protein B by β-glucocerebrosidase deficiency in isogenic dopaminergic neurons from a patient with Gaucher disease and parkinsonism.葡糖脑苷脂酶缺乏对戈谢病和帕金森病患者同基因多巴胺能神经元中糖蛋白非转移性黑色素瘤蛋白B的双向调节
bioRxiv. 2025 Jun 25:2025.06.23.661126. doi: 10.1101/2025.06.23.661126.
2
Comparative study of enriched dopaminergic neurons from siblings with Gaucher disease discordant for parkinsonism.帕金森病症状表现不一致的戈谢病患者同胞中富集的多巴胺能神经元的比较研究。
bioRxiv. 2024 Feb 28:2024.02.25.581985. doi: 10.1101/2024.02.25.581985.
3
Gaucher Disease戈谢病
4
Novel beta-glucocerebrosidase chaperone compounds identified from cell-based screening reduce pathologically accumulated glucosylsphingosine in iPS-derived neuronal cells.从基于细胞的筛选中鉴定出新型的β-葡糖脑苷脂酶伴侣化合物,可减少 iPS 衍生神经元细胞中病理性积累的葡糖基神经酰胺。
SLAS Discov. 2023 Oct;28(7):344-349. doi: 10.1016/j.slasd.2023.06.002. Epub 2023 Jun 25.
5
Evaluation of Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Siblings with Gaucher Disease Discordant for Parkinsonism.对患有戈谢病且帕金森病症状不一致的兄弟姐妹来源的诱导多能干细胞衍生多巴胺能神经元的评估。
Mov Disord. 2025 Jun 26;40(8):1719-24. doi: 10.1002/mds.30273.
6
Inhibition of cysteine protease cathepsin L increases the level and activity of lysosomal glucocerebrosidase.抑制半胱氨酸蛋白酶组织蛋白酶 L 会增加溶酶体葡萄糖脑苷脂酶的水平和活性。
JCI Insight. 2024 Feb 8;9(3):e169594. doi: 10.1172/jci.insight.169594.
7
Classification and Genotype-Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review.GBA1基因变异的分类及基因型-表型关系:MDSGene系统评价
Mov Disord. 2025 Apr;40(4):605-618. doi: 10.1002/mds.30141. Epub 2025 Feb 10.
8
Intrinsic link between PGRN and Gba1 D409V mutation dosage in potentiating Gaucher disease.PGRN 与 Gba1 D409V 突变剂量之间的内在联系增强了戈谢病。
Hum Mol Genet. 2024 Oct 7;33(20):1771-1788. doi: 10.1093/hmg/ddae113.
9
Dissecting the biological impact of mutations using multi-omics in an isogenic setting.在同基因背景下利用多组学剖析突变的生物学影响。
bioRxiv. 2025 Jun 15:2025.06.12.656971. doi: 10.1101/2025.06.12.656971.
10
Adult type I Gaucher disease with splenectomy caused by a compound heterozygous GBA1 mutation in a Chinese patient: a case report.一名中国患者因复合杂合性GBA1突变导致脾切除术后的成人型I型戈谢病:病例报告
Ann Hematol. 2024 May;103(5):1765-1774. doi: 10.1007/s00277-024-05710-2. Epub 2024 Mar 20.

本文引用的文献

1
GPNMB and ATP6V1A interact to mediate microglia phagocytosis of multiple types of pathological particles.GPNMB与ATP6V1A相互作用,介导小胶质细胞对多种类型病理颗粒的吞噬作用。
Cell Rep. 2025 Mar 25;44(3):115343. doi: 10.1016/j.celrep.2025.115343. Epub 2025 Feb 23.
2
African ancestry neurodegeneration risk variant disrupts an intronic branchpoint in GBA1.非洲血统神经退行性疾病风险变异破坏了GBA1基因的一个内含子分支点。
Nat Struct Mol Biol. 2024 Dec;31(12):1955-1963. doi: 10.1038/s41594-024-01423-2. Epub 2024 Dec 12.
3
High-throughput screening for small-molecule stabilizers of misfolded glucocerebrosidase in Gaucher disease and Parkinson's disease.
高通量筛选法筛选用于治疗神经鞘磷脂贮积病和帕金森病的错误折叠葡萄糖脑苷脂酶的小分子稳定剂。
Proc Natl Acad Sci U S A. 2024 Oct 15;121(42):e2406009121. doi: 10.1073/pnas.2406009121. Epub 2024 Oct 10.
4
The annotation of has been concealed by its protein-coding pseudogene .已被其编码蛋白假基因 注释。
Sci Adv. 2024 Jun 28;10(26):eadk1296. doi: 10.1126/sciadv.adk1296. Epub 2024 Jun 26.
5
GPNMB Biomarker Levels in GBA1 Carriers with Lewy Body Disorders.GPNMB 生物标志物水平在携带 GBA1 的路易体障碍患者中。
Mov Disord. 2024 Jun;39(6):1065-1070. doi: 10.1002/mds.29773. Epub 2024 Apr 12.
6
Characterization of Novel Human β-glucocerebrosidase Antibodies for Parkinson's Disease Research.用于帕金森病研究的新型人β-葡萄糖脑苷脂酶抗体的特性分析
J Parkinsons Dis. 2024;14(1):65-78. doi: 10.3233/JPD-230295.
7
Multi-ancestry genome-wide association meta-analysis of Parkinson's disease.多族裔帕金森病全基因组关联荟萃分析。
Nat Genet. 2024 Jan;56(1):27-36. doi: 10.1038/s41588-023-01584-8. Epub 2023 Dec 28.
8
Glucocerebrosidase activity and lipid levels are related to protein pathologies in Parkinson's disease.葡萄糖脑苷脂酶活性和脂质水平与帕金森病中的蛋白质病变有关。
NPJ Parkinsons Dis. 2023 May 11;9(1):74. doi: 10.1038/s41531-023-00517-w.
9
Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolism.葡萄糖脑苷脂酶被导入线粒体,维持了复合物 I 的完整性和能量代谢。
Nat Commun. 2023 Apr 6;14(1):1930. doi: 10.1038/s41467-023-37454-4.
10
Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease.多基因帕金森病遗传风险评分作为戈谢病帕金森综合征的风险修饰因子。
Mov Disord. 2023 May;38(5):899-903. doi: 10.1002/mds.29342. Epub 2023 Mar 3.